Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CDC Says Guidelines Have Reduced Hospital-Acquired Blood Infections

This article was originally published in The Gray Sheet

Executive Summary

Hospital intensive care units reduced central line-associated blood stream infections by 58% in 2009 compared to 2001. The accomplishment largely stems from improving best practices in how those lines are inserted, according to a new report from the Centers for Disease Control and Prevention.

You may also be interested in...



Patient-Safety Efforts To Be Scaled Up In HHS Initiative

HHS plans to unveil "the largest national effort on patient safety ever seen," CMS Administrator Donald Berwick said at a health policy meeting last week in Washington, D.C.

National Healthcare Quality Report Spotlights High Hospital Infection Rates

The Agency for Healthcare Research and Quality says it will intensify efforts to work with other HHS agencies to combat the crisis of health-care-associated infections

Cullinan Changes Tracks, Moving Lymphoma Bispecific Into Autoimmune

The company will discontinue its trial of the CD19-directed bispecific CLN-978 in NHL and develop it in inflammatory diseases, where it could have an edge over CAR-Ts.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029901

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel